Terms: = Cervical cancer AND CYLD, CYLD1, 1540, ENSG00000083799, USPL2, KIAA0849, CYLDI, CDMT, HSPC057, FLJ31664, FLJ20180, EAC AND Staging
3 results:
1. The ISGyP Endocervical Adenocarcinoma Project: Master Plan Summary, Acknowledgment of Participants, and Participant Responses to Final Recommendations of the Expert Panels.
Singh N; Rabban JT
Int J Gynecol Pathol; 2021 Mar; 40 Suppl 1(Iss 2 Suppl 1):S111-S123. PubMed ID: 33687171
[TBL] [Abstract] [Full Text] [Related]
2. New pattern-based personalized risk stratification system for endocervical adenocarcinoma with important clinical implications and surgical outcome.
Roma AA; Mistretta TA; Diaz De Vivar A; Park KJ; Alvarado-Cabrero I; Rasty G; Chanona-Vilchis JG; Mikami Y; Hong SR; Teramoto N; Ali-Fehmi R; Barbuto D; Rutgers JK; Silva EG
Gynecol Oncol; 2016 Apr; 141(1):36-42. PubMed ID: 27016227
[TBL] [Abstract] [Full Text] [Related]
3. Endometrial adenocarcinoma with clinical evidence of cervical involvement: accuracy of diagnostic procedures, clinical course, and prognostic factors.
Leminen A; Forss M; Lehtovirta P
Acta Obstet Gynecol Scand; 1995 Jan; 74(1):61-6. PubMed ID: 7856435
[TBL] [Abstract] [Full Text] [Related]
